Inter J Stomatol ›› 2018, Vol. 45 ›› Issue (6): 628-634.doi: 10.7518/gjkq.2018.06.002
• RNA Research • Previous Articles Next Articles
Yuanyuan Li,Bin Cheng,Yun Wang()
CLC Number:
[1] |
Choi S, Myers JN . Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy[J]. J Dent Res, 2008,87(1):14-32.
doi: 10.1177/154405910808700104 pmid: 18096889 |
[2] |
Ayala FR, Rocha RM, Carvalho KC , et al. GLUT1 and GLUT3 as potential prognostic markers for oral squamous cell carcinoma[J]. Molecules, 2010,15(4):2374-2387.
doi: 10.3390/molecules15042374 pmid: 20428049 |
[3] |
Wang Y, Zhang X, Zhang Y , et al. Overexpression of pyruvate kinase M2 associates with aggressive clini-copathological features and unfavorable pro-gnosis in oral squamous cell carcinoma[J]. Cancer Biol Ther, 2015,16(6):839-845.
doi: 10.1080/15384047.2015.1030551 pmid: 25970228 |
[4] |
Bergmann JH, Spector DL . Long non-coding RNAs: modulators of nuclear structure and function[J]. Curr Opin Cell Biol, 2014,26:10-18.
doi: 10.1016/j.ceb.2013.08.005 |
[5] |
Cech TR, Steitz JA . The noncoding RNA revolution-trashing old rules to forge new ones[J]. Cell, 2014,157(1):77-94.
doi: 10.1016/j.cell.2014.03.008 pmid: 24679528 |
[6] |
Martens-Uzunova ES, Böttcher R, Croce CM , et al. Long noncoding RNA in prostate, bladder, and kid-ney cancer[J]. Eur Urol, 2014,65(6):1140-1151.
doi: 10.1016/j.eururo.2013.12.003 pmid: 24373479 |
[7] | Zhang X, Li Y, Li X , et al. Long non-coding RNA P4713 contributes to the malignant phenotypes of oral squamous cell carcinoma by activating the JAK/STAT3 pathway[J]. Int J Clin Exp Pathol, 2017,10(11):10947-10958. |
[8] |
Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation[J]. Cell, 2011,144(5):646-674.
doi: 10.1016/j.cell.2011.02.013 pmid: 21376230 |
[9] |
El Mjiyad N, Caro-Maldonado A, Ramírez-Peinado S , et al. Sugar-free approaches to cancer cell killing[J]. Oncogene, 2011,30(3):253-264.
doi: 10.1038/onc.2010.466 pmid: 20972457 |
[10] |
Levine AJ, Puzio-Kuter AM . The control of the meta- bolic switch in cancers by oncogenes and tumor sup-pressor genes[J]. Science, 2010,330(6009):1340-1344.
doi: 10.1126/science.1193494 |
[11] |
Gammon L, Biddle A, Heywood HK , et al. Sub-sets of cancer stem cells differ intrinsically in their pat-terns of oxygen metabolism[J]. PLoS One, 2013,8(4):e62493.
doi: 10.1371/journal.pone.0062493 pmid: 23638097 |
[12] |
Bochenek G, Häsler R, El Mokhtari NE , et al. The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10[J]. Hum Mol Genet, 2013,22(22):4516-4527.
doi: 10.1093/hmg/ddt299 |
[13] |
Goncalves MD, Cantley LC . A glycolysis outsider steps into the cancer spotlight[J]. Cell Metab, 2018,28(1):3-4.
doi: 10.1016/j.cmet.2018.06.017 |
[14] |
Coelho RG, Fortunato RS, Carvalho DP . Metabolic reprogramming in thyroid carcinoma[J]. Front Oncol, 2018,8:82.
doi: 10.3389/fonc.2018.00082 |
[15] |
Rupaimoole R, Lee J, Haemmerle M , et al. Long noncoding RNA ceruloplasmin promotes cancer growth by altering glycolysis[J]. Cell Rep, 2015,13(11):2395-2402.
doi: 10.1016/j.celrep.2015.11.047 pmid: 4691557 |
[16] |
Bian Z, Zhang J, Li M , et al. LncRNA-FEZF1-AS1 promotes tumor proliferation and metastasis in co-lorectal cancer by regulating PKM2 signaling[J]. Clin Cancer Res, 2018. doi: 10.1158/1078-0432.CCR-17- 2967.
doi: 10.1158/1078-0432.CCR-17-2967 pmid: 29914894 |
[17] |
Johnson DG, Walker CL . Cyclins and cell cycle checkpoints[J]. Annu Rev Pharmacol Toxicol, 1999,39:295-312.
doi: 10.1146/annurev.pharmtox.39.1.295 pmid: 10331086 |
[18] |
Bloom J, Cross FR . Multiple levels of cyclin speci-ficity in cell-cycle control[J]. Nat Rev Mol Cell Biol, 2007,8(2):149-160.
doi: 10.1038/nrm2105 pmid: 17245415 |
[19] |
Yao F, Zhao T, Zhong C , et al. LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma[J]. Tumour Biol, 2013,34(1):25-31.
doi: 10.1007/s13277-012-0506-0 pmid: 22961700 |
[20] |
Xiao H, Wang J, Yan W , et al. GLUT1 regulates cell glycolysis and proliferation in prostate cancer[J]. Prostate, 2018,78(2):86-94.
doi: 10.1002/pros.23448 pmid: 29105798 |